GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (FRA:QL1A) » Definitions » Cyclically Adjusted Revenue per Share

QuidelOrtho (FRA:QL1A) Cyclically Adjusted Revenue per Share : €25.08 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QuidelOrtho Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

QuidelOrtho's adjusted revenue per share for the three months ended in Mar. 2024 was €9.778. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €25.08 for the trailing ten years ended in Mar. 2024.

During the past 12 months, QuidelOrtho's average Cyclically Adjusted Revenue Growth Rate was 19.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 34.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 34.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of QuidelOrtho was 42.90% per year. The lowest was -4.00% per year. And the median was 5.60% per year.

As of today (2024-05-28), QuidelOrtho's current stock price is €40.20. QuidelOrtho's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €25.08. QuidelOrtho's Cyclically Adjusted PS Ratio of today is 1.60.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of QuidelOrtho was 35.44. The lowest was 1.44. And the median was 6.03.


QuidelOrtho Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for QuidelOrtho's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Cyclically Adjusted Revenue per Share Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.38 8.74 12.34 19.56 23.62

QuidelOrtho Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.80 21.80 23.65 23.62 25.08

Competitive Comparison of QuidelOrtho's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted PS Ratio falls into.



QuidelOrtho Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, QuidelOrtho's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.778/131.7762*131.7762
=9.778

Current CPI (Mar. 2024) = 131.7762.

QuidelOrtho Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.675 100.560 0.885
201409 0.927 100.428 1.216
201412 1.491 99.070 1.983
201503 1.595 99.621 2.110
201506 0.907 100.684 1.187
201509 1.238 100.392 1.625
201512 1.437 99.792 1.898
201603 1.381 100.470 1.811
201606 1.070 101.688 1.387
201609 1.346 101.861 1.741
201612 1.522 101.863 1.969
201703 2.027 102.862 2.597
201706 1.017 103.349 1.297
201709 1.259 104.136 1.593
201712 2.829 104.011 3.584
201803 3.270 105.290 4.093
201806 2.328 106.317 2.885
201809 2.346 106.507 2.903
201812 2.722 105.998 3.384
201903 3.052 107.251 3.750
201906 2.312 108.070 2.819
201909 2.658 108.329 3.233
201912 3.164 108.420 3.846
202003 3.642 108.902 4.407
202006 4.095 108.767 4.961
202009 9.271 109.815 11.125
202012 15.250 109.897 18.286
202103 7.242 111.754 8.539
202106 3.457 114.631 3.974
202109 10.196 115.734 11.609
202112 12.781 117.630 14.318
202203 21.464 121.301 23.318
202206 10.969 125.017 11.562
202209 11.728 125.227 12.341
202212 12.209 125.222 12.848
202303 11.777 127.348 12.187
202306 9.190 128.729 9.408
202309 10.420 129.860 10.574
202312 10.194 129.419 10.380
202403 9.778 131.776 9.778

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


QuidelOrtho  (FRA:QL1A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

QuidelOrtho's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=40.20/25.08
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of QuidelOrtho was 35.44. The lowest was 1.44. And the median was 6.03.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


QuidelOrtho Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (FRA:QL1A) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

QuidelOrtho (FRA:QL1A) Headlines

No Headlines